Tag Archive for: #lifescienceinvestments

Xeltis secures nearly €50m from the European Investment Bank (EIB) and existing shareholders to advance aXess, its vascular access conduit to the market

/in

Up to €37.5m investment from the EIB, consisting of €10m upfront with optionality to further increase by an additional €27.5m €10m investment from existing shareholders including EQT Life Sciences (EQT) and Invest-NL Follows the announcement of excellent EU pivotal trial data highlighting the transformative potential of aXess in hemodialysis treatment European market approval and US […]

Read more

Novo Holdings and EIFO invest €48 million in HealthCap IX to strengthen the Nordic life sciences ecosystem

/in

Novo Holdings and the Export and Investment Fund of Denmark (EIFO) have jointly invested €48 million in HealthCap IX, a Swedish life sciences venture fund focused on building innovative companies in areas of high unmet medical need. Following the investment, HealthCap will establish a local presence in Copenhagen at the BioInnovation Institute (BII) to increase […]

Read more

2023 Novo Holdings Seed Investments Team Annual Review/Business Update

/in

Several significant portfolio financing rounds Launch of SeedLab accelerating company creation with wet lab Four portfolio companies reported significant clinical data Copenhagen, Denmark, 4 January 2024 – Seed Investments, the early-stage investment and company creation team of Novo Holdings, today publishes its review of 2023 – a year of developing and building for long-term results. Read more…

Read more